![]() |
Jonathan Uy, MD |
Dr. Uy's primary research interest is HIV therapy. He is the Principal Investigator of AIDS Research Alliance Chicago, the multi-site Chicago unit of the NIH-funded Community Programs for Clinical Research on AIDS (CPCRA) HIV clinical trials network, and is the national protocol chair for CPCRA 066, Collection and Use of Blood For Genetic and Other Related Analyses. He is co-investigator of the Chicago HIV Vaccines Trials Network (HIVNET) site, an investigator of the CDC HIV Outpatient Study (HOPS), and site principal investigator for multiple industry-sponsored trials. Additionally, Dr. Uy is an HIV educator who has been invited to speak at international conferences in Kenya and Thailand and at many other venues throughout the United States.
In addition, Dr. Uy is the the Chief Scientific Officer of Affordable Medicines for Africa (AMFA), a non-profit organization committed to bringing affordable, quality medications to Africa. AMFA led the establishment of a consortium of several organizations, the Partnership for Supply Chain Management, that was awarded a $77 million USAID contract to procure and deliver life-saving medicines and medical supplies to treat HIV/AIDS patients worldwide.
Education:
Undergraduate: University of Michigan
Medical School : University of Michigan
Residency: University Hospitals of Cleveland/Case Western Reserve University
Fellowship: University of Colorado Health Sciences Center
Selected publications:
- RM Novak, L Chen, RD MacArthur, JD Baxter, K Huppler Hullsiek, G Peng, Y Xiang, C Henley, B Schmetter, J Uy, M van den Berg-Wolf, M Kozal. Prevalence of Antiretroviral Drug Resistance Mutations in Chronically HIV-Infected, Treatment-Naïve Patients: Implications for Routine Resistance Screening before Initiation of Antiretroviral Therapy. Clinical Infectious Diseases, 40:468-74, 2005.
- Uy J. Moving Forward in HIV Medicine. Positively Aware, January/February 2003.
- Stoeckli TC, MaWhinney S, Uy J, Duan C, Lu J, Shugarts D, Kuritzkes DR. Phenotypic and Genotypic Analysis of Biologically Clones HIV-1 Isolates from Patients Treated with Zidovudine and Lamivudine. Antimicrobial Agents and Chemotherapy, 46 (12):4000-3, 2002.
.

